Please assess the completion status of the following clinical trial:

Trial Title: Non-Idiopathic Scoliosis Treated With Tranexamic Acid

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Children with secondary scoliosis undergoing posterior spinal fusion~Exclusion Criteria:~1. Known bleeding disorder as this may increase the risk of bleeding~2. Current antifibrinolytic therapy as these patients may bleed less~3. Patient or family history of thromboembolic disease as there may be potential risk of thrombosis~4. Use of NSAIDS within 5 days of surgery as this may increase the risk of bleeding~5. Known allergy to TXA~6. History of renal insufficiency as TXA is renally excreted~7. Colour vision disturbance

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- . Tranexamic acid low dose 10 mg/kg (Type: EXPERIMENTAL): None
- Tranexamic acid 100mg/kg (Type: EXPERIMENTAL): None
- Saline Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).